P4‐002: A FRAILTY INDEX BASED ON ROUTINELY COLLECTED LABORATORY SAFETY DATA PREDICTS DROPOUT IN ALZHEIMER DISEASE CLINICAL TRIAL SETTINGS. (1st July 2019)